Cargando…
How do we avoid disaster when exiting the European Medicines Agency? Making the most of Brexit in pharmaceutical regulation
As the UK prepares to leave the EU, it must decide what path it is to take with a large number of regulatory and technical agencies who provide collaboration at the European level. In the case of pharmaceuticals, the European Medicines Agency (EMA) provides pan-European licencing for novel pharmaceu...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Cancer Intelligence
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5493438/ https://www.ncbi.nlm.nih.gov/pubmed/28717397 http://dx.doi.org/10.3332/ecancer.2017.ed67 |